Therefore, defects in autophagic clearance of lipid droplets triggered by the MAP1S deficiency may stimulate the initiation, development and metastasis of ccRCC, and reduce the survival of ccRCC patients. Here, MAP1S is linked to nonpapillary renal cell carcinoma.